Announcements Trials

Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1 NET 1 Endocrine 1

Conditions

Pituitary Diseases 1 Neuroendocrine Tumors 1 Neoplasms 1

Interventions

Everolimus 5 Sunitinib 4 lutetium Lu 177 dotatate 2 PM 01183 2 Octreotide 2 Doxorubicin 2 trifluridine tipiracil drug combination 1 telotristat ethyl 1 repotrectinib 1 pralsetinib 1 pegfilgrastim 1 pasireotide 1 motesanib diphosphate 1 epothilone B 1 dactolisib 1 copper dotatate CU-64 1 batifiban 1 avelumab 1 alectinib 1 Temozolomide 1 TKM-080301 1 Surveys and Questionnaires 1 SNX-5422 1 Referral and Consultation 1 Radiomics 1 Quality of Life 1 Patient Reported Outcome Measures 1 Oxaliplatin 1 Molecular Diagnostic Techniques 1 Lutetium-177 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Radiomics × NET × Clear all

NCT06607198 2024-09-23

PitNET2024

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Not yet recruiting

Neoplasms, Pituitary Diseases, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡